By Manufacturer Type

White-Label / CDMO-Sourced Kits Market Analysis

Cross-industry research covering White-Label / CDMO-Sourced Kits across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering White-Label / CDMO-Sourced Kits

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

A growing ecosystem of white-label DTC operators purchases sequencing services from CDMO-positioned laboratories and resells under proprietary brands, primarily in the wellness and nutrigenomics space. Regulatory accountability for the underlying test quality in this tier is diffuse.

14%

Market Share

7.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments